Airware Labs Hires Schultz Public Relations, LLC as Market Adoption Surges
ACCESSWIRE - Wed Jan 14, 8:15AM CST
Firm to Highlight Solutions to Health Challenges and Landmark Product Adoption
AirWare Labs Files Patent Applications for Innovative Nasal Drug Delivery System
ACCESSWIRE - Thu Nov 13, 7:17AM CST
Nasal Insufflation Exceeds Oral Administration of Medications in Efficiency, Absorption Rate and Ease of Use
AirWare Labs Files Patent Application for Cutting-Edge Nasal CPAP Treatment System
eTeligis - Wed Nov 05, 7:01AM CST
SCOTTSDALE, AZ, United States, via ETELIGIS INC., 11/05/2014 - - AirWare Labs Corp. (OTCQB: AIRW) today announced the filing of a new patent application for a cutting-edge CPAP (Continuous Positive Airway Pressure) treatment system that replaces bulky, uncomfortable CPAP masks with a streamlined nasal design that promotes a restful night's sleep.
AirWare Labs Launches Revolutionary New Skin Care Line to Treat Wrinkles, Acne, Scars and Warts
Marketwired - Tue Oct 28, 7:00AM CDT
AirWare Labs Corp. (OTCQB: AIRW) today announced it has launched a line of skin care products that utilize pharmaceutical-grade serums in a patented treatment system designed to enhance and provide youthful benefits to the skin.
AirWare Labs Files Patent Application for Revolutionary Oxygen Cannula Delivery System
Marketwire - Wed Jul 09, 7:10AM CDT
AirWare Labs Corp. (OTCQB: AIRW) today announced the filing of a new patent application for a revolutionary oxygen cannula delivery system, expected to launch later this year. The system will feature a proprietary cannula design, fitted with disposable nasal dilators that diffuse the stream of oxygen as it enters the nasal passage and prevent the nasal dryness, irritation and discomfort commonly reported by cannula users. The nasal dilators also work to open the nasal passage and increase airflow by up to 60%, enhancing the overall effectiveness of oxygen therapy.